Video

Optune User Journey: Meet Steve

Author(s):

Sponsored Content

Watch a video about Steve, an Optune user. Learn how Steve manages his treatment while enjoying his favorite activities.

Sponsored Content

Sponsored Content

Watch a video about Steve, an Optune user. Learn how Steve manages his treatment while enjoying his favorite activities at http://www.optune.com.

Hear firsthand from an Optune user and caregiver, like Steve.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Some patients with relapsed/refractory diffuse large B-cell lymphoma whose disease progressed after CAR-T cell therapy, responded to odronextamab.
Odronextamab Elicits Responses in Some With Lymphoma Following CAR-T
Anne M. Reb is a nurse practitioner with City of Hope.
Overcoming Barriers to Emotional and Physical Support in Cancer Care
Image of woman with brown hair.
Raising Awareness for Adolescents and Young Adults with Cancer
Image of man with black hair.
Bavencio Maintains Bladder Cancer Benefit in Patients with Diabetes
Image of bald man.
Recognizing Symptoms During Head and Neck Cancer Awareness Month
Image of man.
Dr. Grivas Highlights Three Practice-Changing Trials in Bladder Cancer
Image of Kumar.
Raising Awareness on Multidisciplinary Approaches in GI Cancers
Dr. Elizabeth K. Lee discusses the RAINFOL-01 clinical trial evaluating treatment with Rina-S in advanced ovarian cancer.
Breaking Down The Use of Rina-S in Advanced Ovarian Cancer
Melanoma is a key cancer type for developing and testing immunotherapies prior to broader clinical application across other malignancies.
Understanding How to Advance Immunotherapy Strategy Models in Melanoma
Image of Dr. Kumar.
Radiation Therapy Advances Improve Quality of Life for GI Cancer
Related Content
FDA sign.
April 23rd 2025

FDA Grants Breakthrough Status to CAR-T Therapy for Pediatric Brain Tumor

Ryan Scott
The FDA granted breakthrough therapy designation to an autologous CAR-T cell therapy for pediatric patients with diffuse intrinsic pontine glioma.
Site Logo
August 29th 2019

Earning Your Legacy: Cancer Has Nothing To Do With It

Kristie L. Kahl
In this episode of the “CURE Talks Cancer” podcast, we spoke with Matt Newman, who was diagnosed with brain cancer at 39, but refuses to let cancer define the legacy he has made.
Illustration of brain.
April 15th 2025

Clinical Trial of NEO100 Recruiting Patients With Malignant Gliomas

Alex Biese
A phase 2a clinical trial of NEO100-01 is continuing to recruit patients with malignant gliomas, with full enrollment expected in September.
Site Logo
April 11th 2019

Addressing Nutritional Needs in Cancer

Kristie L. Kahl
In this week’s episode, we spoke with the founder and CEO of Savor Health on the importance of nutrition for patients and caregivers before, during and after cancer treatment.
Illustration of brain.
April 4th 2025

FDA Grants Rare Pediatric Designation to Treatment With NEO100 in Brain Cancer

Ryan Scott
The FDA has granted Rare Pediatric Disease Designation for NEO100 in the treatment of pediatric-type diffuse high-grade gliomas, a type of brain cancer.
image of dr. Lillian Siu.
April 3rd 2025

Breaking Down Early Signs and Symptoms of Head and Neck Cancer

Dr Lillian Siu
April is Head and Neck Cancer Awareness Month, and it is important to be aware of early signs and symptoms of the disease, as well as when to seek care.